This was confirmed in CML patients, for whom we found BCR::ABL1/GUSB levels at diagnosis were apparently elevated in e13a2 cases compared to e14a2 when using RT-qPCR, but no difference was seen with ddPCR. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.